Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexyRichard Bogan, Karel Šonka, Michael J. Thorpy et al.|SLEEP|2020Cited by 72
Clinical considerations for the diagnosis of idiopathic hypersomniaYves Dauvilliers, Michael J. Thorpy, Isabelle Arnulf et al.|Sleep Medicine Reviews|2022Cited by 71
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyYves Dauvilliers, Richard Bogan, Isabelle Arnulf et al.|The Lancet Neurology|2021Cited by 67
Lower-Sodium Oxybate Dose Titration and Transition From Sodium Oxybate in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adult Participants With Narcolepsy With Cataplexy (2163)Nancy Foldvary‐Schaefer, Yves Dauvilliers, Richard Bogan et al.|Neurology|2021Cited by 1
Cataplexy-Free Days in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Narcolepsy With Cataplexy (2065)Yves Dauvilliers, Michael J. Thorpy, Richard Bogan et al.|Neurology|2021Cited by 1